10x Genomics (TXG) Interest Expenses (2018 - 2025)

10x Genomics has disclosed Interest Expenses across 8 years of filings, most recently posting -$3000.0 for Q3 2025.

• Interest Expenses for Q3 2025 came in at -$3000.0, down 250.0% year-over-year; the trailing twelve-month figure through Jun 2025 was $5000.0 (down 54.55% YoY), and the FY2024 annual result was $4000.0, down 87.88% from the prior year.
• Interest Expenses came in at -$3000.0 for Q3 2025 at 10x Genomics, down from $3000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $221000.0 in Q1 2021 to a low of -$3000.0 in Q3 2025.
• The 5-year median for Interest Expenses is $19000.0 (2023), against an average of $81117.6.
• Peak annual rise in Interest Expenses reached 200.0% in 2025, while the deepest fall reached 250.0% in 2025.
• 10x Genomics' Interest Expenses stood at $217000.0 in 2021, then slumped by 42.4% to $125000.0 in 2022, then tumbled by 93.6% to $8000.0 in 2023, then slumped by 75.0% to $2000.0 in 2024, then tumbled by 250.0% to -$3000.0 in 2025.
• The last three Interest Expenses figures came in at -$3000.0 (Q3 2025), $3000.0 (Q2 2025), and $2000.0 (Q3 2024), per Business Quant data.